Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets.Â
Global Epilepsy Therapeutics Market is valued approximately USD 0.85 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.52%% over the forecast period 2023-2030. Epilepsy is a chronic noncommunicable disease of the brain that is characterized by recurrent, unprovoked seizures and affects people of all age group. These seizures are occurred due to the abnormal electrical activity in the brain, leading to various symptoms behavior, awareness, sensation, or consciousness depending on the affected area. This neurological condition is expected to cause by brain injury, tumor, stroke, infection, and genetic predisposition. Therapeutics such as Antiepileptic Drugs (AEDs), surgical devices, and other surgical instruments are introduced in order to cure epilepsy.
The objective of epilepsy therapeutics is to control and manage seizures, improve the quality of life for individuals with epilepsy, and minimize the adverse effects of medications. The growing geriatric population, rising number of research & development activities related to epilepsy therapeutics, and rise in the new drug approvals are the key factors that anticipated to support the market growth across the globe. For instance, in March 2022, the U.S. Food and Drug Administration (FDA) granted approval for Ztalmy (ganaxolone) to address seizures linked with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients aged two years and above.
In addition, the rising prevalence of epilepsy worldwide have been is a significant factor driving the demand for epilepsy therapeutics. Epilepsy is a neurological condition marked by repeated and unpredictable seizures, which are abnormal, excessive electrical discharges in the brain. Growing seizures play a complex and multifaceted role in the development of epilepsy, encompassing genetic, environmental, and neurological variables. Furthermore, frequent seizures can promote the development of epilepsy. The brain’s sensitivity to seizures can rise over time as a result of a phenomenon known as kindling, in which numerous or prolonged seizures reduce the threshold for future seizures.
For further analysis on the study, request a sample copy
This process has the potential to start a cycle that increases the brain’s susceptibility to the unprovoked, spontaneous seizures that are a characteristic of epilepsy. According to the World Health Organisation, epilepsy affects around 50 million people globally, making it one of the most common neurological diseases. Nearly 80% of epilepsy patients live in low- and middle-income countries. In addition, according to the World Health Organisation, epilepsy affects around 50 million people globally, making it one of the most common neurological diseases. Nearly 80% of epilepsy patients live in low- and middle-income countries.
Moreover, technological advancements associated to epilepsy-based therapeutics devices, as well as government awareness campaigns regrading epilepsy are anticipated to create the lucrative opportunities for the market growth over forecast period of 2023-2030. However, the side effects associated to anti-epilepsy medications and high treatment cost associated to epilepsy are likely to stifles the market growth during the estimated years.
Among Product Type, the market is studied under Antiepileptic Drugs (AEDs), Devices and Surgical Instruments. Among these segments, antiepileptic drugs consistently dominate due to their widespread use as first-line treatment for epilepsy management. AEDs remain the primary choice for physicians and patients due to their established efficacy in seizure control, relatively low cost compared to surgical interventions, and the availability of multiple drug options catering to diverse patient needs and tolerances. These factors collectively drive the dominance of antiepileptic drugs as the leading product category in the epilepsy therapeutics market.
Among End Users, the market is studied under Hospitals, Clinics and Home Care Settings. Hospitals emerge as the dominant segment with a 48.27% market share in 2022. This is primarily attributed to hospitals serving as primary centers for diagnosis, treatment, and management of epilepsy cases, offering comprehensive care facilities, specialized equipment, and multidisciplinary healthcare teams.
Global Epilepsy Therapeutics Market is studied under 5 major regions, namely, North America, Latin America, Asia pacific, Europe and Middle East & Africa. North America emerges as the dominating region in the global epilepsy therapeutics market, driven by factors such as well-established healthcare infrastructure, high healthcare expenditure, and technological advancements. In the United States and Canada, robust research and development activities, coupled with a favorable regulatory environment, foster innovation in epilepsy therapeutics. Additionally, increasing awareness about epilepsy, along with initiatives by patient advocacy groups, further fuel market growth.
Moreover, the presence of key pharmaceutical companies and academic research institutions contributes to the region’s leadership in epilepsy treatment advancements. Europe represents a significant market for epilepsy therapeutics, characterized by a mature healthcare system, high prevalence of epilepsy, and increasing adoption of novel treatment modalities. Countries like the United Kingdom, Germany, France, and Italy are key contributors to market growth, owing to their strong pharmaceutical sectors and research capabilities. Furthermore, supportive government policies, reimbursement schemes, and initiatives to improve epilepsy awareness and access to treatment contribute to market expansion in the region.
Major market player included in this report are:
Pfizer, Inc.
UCB S.A.
Bausch Health Companies Inc.
Novartis AG
GlaxoSmithKline plc.
Boston Scientific Corporation
Sumitomo Pharma Co., Ltd.
Eisai Co. Ltd
Upsher-Smith Laboratories, LLC
Aleva Neurotherapeutics
Recent Developments in the Market:
Global Epilepsy Therapeutics Market Report Scope:
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Antiepileptic Drugs (AEDs)
Devices
Surgical Instruments
By End User:
Hospitals
Clinics
Home care settings
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Chapter 1.             Executive Summary
Chapter 2.             Global Epilepsy Therapeutics Market Definition and Scope
Chapter 3.             Global Epilepsy Therapeutics Market Dynamics   Â
Chapter 4.             Global Epilepsy Therapeutics Market Industry Analysis
Chapter 5.             Global Epilepsy Therapeutics Market, by Product Type
Chapter 6.             Global Epilepsy Therapeutics Market, by End User
Chapter 7.             Global Epilepsy Therapeutics Market, Regional Analysis
Â
Chapter 8.             Competitive Intelligence
Chapter 9.             Research Process
Research Methodology:
At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts.
This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. Â These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.
Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.
24x7 Chat Support plus
free analyst hours with every purchase
Our 360-degree approach of market study, our research methods leave stones unturned.
Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We offer wide range of services including Syndicated Reports, Customized Reports, Competitive Intelligence and others.
